GlassScriptPhysician profile
Alisha Amendt
NPI 1114003027
$6,552.70
in general payments reported to CMS, 2019-2025
40 companies · $1,779 in 2025
The $1,779 reported for 2025 was more than what 92% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $742 · 2022: $1,589 · 2023: $1,166 · 2024: $1,277 · 2025: $1,779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,222.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,426.99 | 2021-2025 | |
| Sk Life Science, INC. | $407.97 | 2022-2025 | Xcopri |
| Upsher-Smith Laboratories LLC | $368.97 | 2021-2023 | |
| Amgen INC. | $363.35 | 2021-2025 | Repatha, Aimovig |
| Lilly USA, LLC | $308.95 | 2021-2024 | Emgality, Amyvid, Reyvow |
| Tg Therapeutics, INC. | $274.97 | 2025 | |
| Pfizer INC. | $238.79 | 2023-2025 | |
| Amneal Pharmaceuticals LLC | $179.74 | 2021-2025 | Rytary, Ongentys |
| Lundbeck LLC | $171.37 | 2021-2025 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $170.91 | 2021-2024 | Austedo Xr, Austedo |
| Argenx US, INC. | $155.59 | 2022-2024 | Vyvgart Hytrulo, Vyvgart |
| Biohaven Pharmaceutical Holding Company LTD. | $152.86 | 2022 | |
| Ceribell, INC. | $144.30 | 2025 | Pocket Eeg Device |
| Allergan, INC. | $127.33 | 2021 | |
| Merz Pharmaceuticals, LLC | $126.48 | 2021-2025 | Inbrija, Xeomin |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisha Amendt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.